Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nanoparticles targeting immune checkpoint protein VISTA induce potent antitumor immunity

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-008977Source: DataRank Database

Nanoparticles targeting immune checkpoint protein VISTA induce potent antitumor immunity is a research paper published in Journal for ImmunoTherapy of Cancer (2024). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)Impact (FWCI 2.11)OA: goldTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Hieu Minh Ta ORCID,Anubhuti Bhalotia,Kai E. Paulsen,Diarmuid W. Hutchinson,Gabrielle M Arkema

Live enrichment

PubMed:39209454 PMC:PMC11367342 OpenAlex:https://openalex.org/W4402015848

National Cancer Institute

Grant: P30CA043703

National Cancer Institute

Grant: R01CA223804

National Cancer Institute

Grant: R01CA253627

National Cancer Institute

Grant: R01CA278633

National Cancer Institute

Grant: R21CA258618

Congressionally Directed Medical Research Programs

Grant: W81XWH-21-LCRP-IITRA LC210336

Congressionally Directed Medical Research Programs

Grant: W81XWH-21-MRP-MCAA ME210229

American Cancer Society

Grant: RSG-18-045-01-LIB

NIH Interdisciplinary Biomedical Imaging Training Program

Grant: T32EB007509

National Science Foundation

Grant: N/A

NCI NIH HHS

Grant: R01 CA164225

National Institutes of Health

Grant: 1R21CA258618-01A1

The Roles of a Novel Immune-Checkpoint Receptor Complex in Driving T Cell Dysfunction in Cancer

National Institutes of Health

Grant: 5R01CA278633-02

Dual action immunostimulatory nanoparticles for treatment of aggressive cancers

National Institutes of Health

Grant: 5R01CA253627-05

Targeted immuno-nanoparticles for directing antitumor immune response against breast cancer metastasis

National Institutes of Health

Grant: 5R01CA223804-03

Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer

National Institutes of Health

Grant: 5T32EB007509-18

Interdisciplinary Biomedical Imaging Training Program

National Institutes of Health

Grant: 3P30CA043703-20S1

Case Comprehensive Cancer Center Support Grant

FWCI

2.11

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by-nc

journalhttps://jitc.bmj.com/content/12/8/e008977.full.pdf

publisherhttps://jitc.bmj.com/content/12/8/e008977.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1136/jitc-2024-008977

journalhttps://doi.org/10.1136/jitc-2024-008977

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39209454

Fields of Study

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesImmune cells in cancer0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsFemaleHumansImmunotherapyMelanoma, ExperimentalMice, Inbred C57BLCell Line, TumorToll-Like Receptor 9MiceNanoparticlesB7 Antigens

Keywords

Immune checkpointImmunityImmune systemMedicineImmunologyCancer researchImmunotherapyGene therapyVaccineNanoparticleImmune Checkpoint InhibitorB7 AntigensMelanoma, ExperimentalNeoplasms. Tumors. Oncology. Including cancer and carcinogensMice, Inbred C57BLOncolytic and Local ImmunotherapyMiceCell Line, TumorToll-Like Receptor 9AnimalsNanoparticlesHumansFemaleRC254-282

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Nanoparticles targeting immune checkpoint protein VISTA induce potent antitumor immunity

FAIR Checklist

Authors (12)

Funding (17 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)